Exro Announces Merger with SEA Electric to Create Leading e-Mobility Technology Company and Concurrent C$42 Million Capital Raise Transactions
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO... Read more.
Lendica and CSG Forte Partnership Ushers in New Era of Embedded Business Lending
BOSTON, Jan. 30, 2024 /PRNewswire/ — Lendica, an embedded AI lending company, and CSG Forte, a CSG® (NASDAQ: CSGS) company and a leader in complete and customizable... Read more.
AlphaGraphics celebrates fifth consecutive year on Entrepreneur’s Franchise 500® list
The franchisor setting the standard for excellence in printing and marketing solutions DENVER, Jan. 30, 2024 /PRNewswire/ — AlphaGraphics, a leading franchisor... Read more.
Now Available: Veeva Compass Suite of Commercial Data Products
Complete suite of modern patient, prescriber, and national data products for today’s complex therapies Compass Prescriber includes HCP-level projections for... Read more.
Shutterstock Increases Quarterly Dividend By 11% to $0.30
New York, Jan. 30, 2024 /PRNewswire/ — Shutterstock, Inc. (NYSE: SSTK), a leading global creative platform connecting brands and businesses to high-quality... Read more.
Sensorium Therapeutics Expands Board Leadership with Addition of Simba Gill, Ph.D., as Independent Director
Gill brings decades of leadership experience building biotech companies, transformative platforms and developing products The company announces first Development... Read more.
Chemomab Therapeutics Announces New Publication Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis
—Proteomic Analysis of Human Samples Highlights the Unique Role of CCL24 in Activating Key PSC-related Disease Mechanisms Involving Immune Cell Trafficking and... Read more.
A faster, more efficient imaging system for nanoparticles
A new technique developed at INRS pushes back some of the limits of the infrared imaging of rare-earth doped nanoparticles. VARENNES, QC, Jan. 30, 2024 /CNW/ –... Read more.
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics
SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma,... Read more.
Procede Software Continues to Deliver on its Commitment to Advancing its Industry-Leading Dealer Management System with Excede v10.4 Release
By leveraging its user-centered design strategy and proactively listening to subject matter experts and daily users, the company continues to deliver significant... Read more.